5M6N image
Entry Detail
PDB ID:
5M6N
Keywords:
APOPTOSIS
Title:
Small Molecule inhibitors of IAP
Biological Source:
Source Organism:
Homo sapiens
Host Organism:
Escherichia coli BL21(DE3)
PDB Version:
Deposition Date:
2016-10-25
Release Date:
2017-05-24
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
1.80 Å
R-Value Free:
0.20
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 21
5M6N validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Description:Baculoviral IAP repeat-containing protein 2
Mutations:Deletion 1-266, deletion 364-619, insertion 266 MGSSHHHHHH SSGLVPRGSHM
Chain IDs:A, B
Chain Length:118
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:Q13490 Pfam ID:PF00653
Ligand Molecules
7H9
SO4
ZN
Primary Citation
Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP).
J. Med. Chem. 60 4611 4625 (2017)
PMID: 28492317 DOI: 10.1021/acs.jmedchem.6b01877

Abstact

XIAP and cIAP1 are members of the inhibitor of apoptosis protein (IAP) family and are key regulators of anti-apoptotic and pro-survival signaling pathways. Overexpression of IAPs occurs in various cancers and has been associated with tumor progression and resistance to treatment. Structure-based drug design (SBDD) guided by structural information from X-ray crystallography, computational studies, and NMR solution conformational analysis was successfully applied to a fragment-derived lead resulting in AT-IAP, a potent, orally bioavailable, dual antagonist of XIAP and cIAP1 and a structurally novel chemical probe for IAP biology.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
5M6N